Cargando…

Action of irbesartan on blood pressure and glucose/lipid metabolism, in hemodialysis patients with hypertension

BACKGROUND: Irbesartan has been reported to have beneficial effects on glucose/lipid metabolism in addition to an antihypertensive effect; however, such effects have not been clarified in hemodialysis (HD) patients. We investigated the effects of irbesartan on blood pressure (BP) as well as glucose/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Onishi, Akira, Morishita, Yoshiyuki, Watanabe, Minami, Numata, Akihiko, Tezuka, Mikio, Okuda, Kosuke, Tsunematsu, Sadao, Sugaya, Yasuhiro, Hashimoto, Shinichi, Kusano, Eiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674020/ https://www.ncbi.nlm.nih.gov/pubmed/23761980 http://dx.doi.org/10.2147/IJGM.S43850

Ejemplares similares

Long-term effects of aliskiren on blood pressure and the renin-angiotensin-aldosterone system in hypertensive hemodialysis patients
por: Morishita, Yoshiyuki, et al.
Publicado: (2012)

Aliskiren suppresses the renin–angiotensin–aldosterone system and reduces blood pressure and albuminuria in elderly chronic kidney disease patients with hypertension
por: Morishita, Yoshiyuki, et al.
Publicado: (2012)

Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
por: Akimoto, Tetsu, et al.
Publicado: (2014)

Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
por: Morishita, Yoshiyuki, et al.
Publicado: (2014)

The Interaction of LFA-1 on Mononuclear Cells and ICAM-1 on Tubular Epithelial Cells Accelerates TGF-β1-Induced Renal Epithelial-Mesenchymal Transition
por: Morishita, Yoshiyuki, et al.
Publicado: (2011)

Primary care physicians’ own exercise habits influence exercise counseling for patients with chronic kidney disease: a cross-sectional study
por: Morishita, Yoshiyuki, et al.
Publicado: (2014)

Level of 8-OHdG in drained dialysate appears to be a marker of peritoneal damage in peritoneal dialysis
por: Morishita, Yoshiyuki, et al.
Publicado: (2011)

siRNAs targeted to Smad4 prevent renal fibrosis in vivo
por: Morishita, Yoshiyuki, et al.
Publicado: (2014)

Direct Renin Inhibitor: Aliskiren in Chronic Kidney Disease
por: Morishita, Yoshiyuki, et al.
Publicado: (2012)

Methylglyoxal Induced Basophilic Spindle Cells with Podoplanin at the Surface of Peritoneum in Rat Peritoneal Dialysis Model
por: Hirahara, Ichiro, et al.
Publicado: (2015)

Irbesartan in experimental diabetic nephropathy
por: Mahajan, Rajiv, et al.
Publicado: (2010)

Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease
por: Akimoto, Tetsu, et al.
Publicado: (2012)

Endothelial effects of antihypertensive treatment: focus on irbesartan
por: Negro, Roberto
Publicado: (2008)

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009)

Biochemical effects of irbesartan in experimental diabetic nephropathy
por: Vaishya, Richa, et al.
Publicado: (2009)

Association of primary care physicians’ exercise habits and their age, specialty, and workplace
por: Morishita, Yoshiyuki, et al.
Publicado: (2013)

Long-term use and tolerability of irbesartan for control of hypertension
por: Forni, Valentina, et al.
Publicado: (2011)

Irbesartan improves arterial compliance more than lisinopril
por: Ali, Khalid, et al.
Publicado: (2009)

Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
por: Gialama, Fotini, et al.
Publicado: (2013)

Late-Onset Rash from Irbesartan: An Immunological Reaction
por: Cardoso, Bárbara Kong, et al.
Publicado: (2019)

Changes of Necroptosis in Irbesartan Medicated Cardioprotection in Diabetic Rats
por: Xu, Qingmei, et al.
Publicado: (2021)

Exercise counseling of primary care physicians in metabolic syndrome and cardiovascular diseases is associated with their specialty and exercise habits
por: Morishita, Yoshiyuki, et al.
Publicado: (2014)

Effects of Raloxifene on Bone Metabolism in Hemodialysis Patients With Type 2 Diabetes
por: Saito, Osamu, et al.
Publicado: (2012)

Irbesartan Induced Cutaneous Melanoma! Second Case in the Medical Literature!
por: Tchernev, Georgi, et al.
Publicado: (2019)

Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity
por: Puri, Vivek, et al.
Publicado: (2020)

The effect of solution environment and the electrostatic factor on the crystallisation of desmotropes of irbesartan
por: Araya-Sibaja, Andrea M., et al.
Publicado: (2019)

A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan
por: Yoo, Seo Yeon, et al.
Publicado: (2022)

Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy
por: Liu, Jie, et al.
Publicado: (2022)

Formulation and development of a self-nanoemulsifying drug delivery system of irbesartan
por: Patel, Jaydeep, et al.
Publicado: (2011)

Efficacy of Irbesartan on Left Ventricular Mass and Arterial Stiffness in Hypertensive Patients
por: Park, Chang Gyu, et al.
Publicado: (2006)

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
por: Nakamura, Makiko, et al.
Publicado: (2014)

Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
por: Jones, M. R., et al.
Publicado: (2016)

Irbesartan desmotropes: Solid-state characterization, thermodynamic study and dissolution properties
por: Araya-Sibaja, Andrea Mariela, et al.
Publicado: (2019)

Nanocrystalline Suspensions of Irbesartan Enhance Oral Bioavailability by Improving Drug Solubility and Leading Endocytosis Uptake into the Intestine
por: Deguchi, Saori, et al.
Publicado: (2021)

Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria: An Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) substudy
por: Broedbaek, Kasper, et al.
Publicado: (2011)

A Case of Diffuse Endocapillary Proliferative Glomerulonephritis Associated with Polymyalgia Rheumatica
por: Takeshima, Eri, et al.
Publicado: (2012)

Experiencia clínica de Irbesartán a lo largo del espectro de la enfermedad cardiovascular : ampliando evidencia con Irbesartan
Publicado: (2007)

Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey
por: Burnier, Michel, et al.
Publicado: (2005)

A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazide
por: Khodke, Amol S, et al.
Publicado: (2010)

Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation
por: Wang, Xuewen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_itj5n982bo2je4i7vos7ee453t